Cite
B-VITAMIN THERAPY LOWERS HOMOCYSTEINE AND IMPROVES SELECTIVE COGNITIVE OUTCOMES IN THE RANDOMIZED FAVORIT ANCILLARY COGNITIVE TRIAL.
MLA
Troen, Aron M., et al. “B-Vitamin Therapy Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized Favorit Ancillary Cognitive Trial.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 13, July 2017, p. P609. EBSCOhost, https://doi.org/10.1016/j.jalz.2017.06.661.
APA
Troen, A. M., Scott, T., Rogers, G., Weiner, D. E., Livingston, K., Selhub, J., Jacques, P. F., & Rosenberg, I. H. (2017). B-Vitamin Therapy Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized Favorit Ancillary Cognitive Trial. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 13, P609. https://doi.org/10.1016/j.jalz.2017.06.661
Chicago
Troen, Aron M., Tammy Scott, Gail Rogers, Daniel E. Weiner, Kara Livingston, Jacob Selhub, Paul F. Jacques, and Irwin H. Rosenberg. 2017. “B-Vitamin Therapy Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized Favorit Ancillary Cognitive Trial.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 13 (July): P609. doi:10.1016/j.jalz.2017.06.661.